secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medicine Man Technologies, Inc. (—)
CIK:        0001622879
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001104659-24-125507
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Schwazze restates 2022-2023 financials; prior statements no longer reliable
---------------------------------------------------------------------------

- Audit committee determined restatement needed for FY 2022, 2023, and Q1-Q3 2023 interim periods due to accounting errors.
- Corrections include reclassification of preferred shares, operating leases, purchase accounting, inventory, debt, goodwill impairment.
- Prior auditor BF Borgers was suspended by SEC in May 2024; re-audit by Baker Tilly underway.
- Company does not expect negative material impact on revenue, adjusted EBITDA, cash from operations.
- Previously issued reports and earnings releases for Subject Periods should no longer be relied upon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924125507/0001104659-24-125507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1622879/000110465924125507/tm2430193d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-125507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer